Company Number: 14718741

Analysis Date: 2025-07-29 18:05 UTC

1. Risk Rating: LOW
   The company is newly incorporated (March 2023) and presents positive net assets and net current assets as at its first accounting reference date. There are no overdue filings, and the business operates on a micro-entity basis, which limits complexity and associated reporting risks.

2. Key Concerns:

• Limited Operating History: The company has less than two years of trading history, which restricts the ability to assess financial performance trends or resilience.
• Single Director and Shareholder Control: Mr. Prabhjot Singh Bhurjee holds 75-100% ownership and voting rights, which centralizes control and could raise governance concerns if succession or continuity planning is absent.
• Modest Capital Base: Share capital is minimal (£11), indicating limited initial financial buffer, though net assets are higher due to retained earnings or contributed reserves.

3. Positive Indicators:

• Strong Liquidity Position: Current assets (£38,675) significantly exceed current liabilities (£17,846), resulting in net current assets of £20,829, which suggests adequate short-term liquidity.
• Compliance and Timely Filings: Accounts and confirmation statements are filed on time with no overdue filings or penalties noted.
• Clear Regulatory Status: The company is active, not in liquidation or administration, and no director disqualifications or governance red flags are apparent.

4. Due Diligence Notes:

• Verify Revenue and Profitability: Since profit and loss accounts were not filed publicly, confirm trading performance and cash flow generation capabilities.
• Understand Business Model and Client Base: Given the SIC codes (general medical practice and dispensing chemist), confirm the sustainability of income streams and regulatory compliance with healthcare standards.
• Review Director’s Background and Financial Support: Assess Mr. Bhurjee’s experience and financial backing to support ongoing operations and potential growth.